4-(pyrazolo[1,5-a]pyrimidin-3-yl)quinoline

ID: ALA512294

Chembl Id: CHEMBL512294

PubChem CID: 44577771

Max Phase: Preclinical

Molecular Formula: C15H10N4

Molecular Weight: 246.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  c1ccc2c(-c3cnn4cccnc34)ccnc2c1

Standard InChI:  InChI=1S/C15H10N4/c1-2-5-14-12(4-1)11(6-8-16-14)13-10-18-19-9-3-7-17-15(13)19/h1-10H

Standard InChI Key:  TWMAPZXJXKGZOT-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

BMP4 Tchem Bone morphogenetic protein 4 (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 246.27Molecular Weight (Monoisotopic): 246.0905AlogP: 2.94#Rotatable Bonds: 1
Polar Surface Area: 43.08Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.45CX LogP: 2.46CX LogD: 2.46
Aromatic Rings: 4Heavy Atoms: 19QED Weighted: 0.52Np Likeness Score: -1.48

References

1. Cuny GD, Yu PB, Laha JK, Xing X, Liu JF, Lai CS, Deng DY, Sachidanandan C, Bloch KD, Peterson RT..  (2008)  Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors.,  18  (15): [PMID:18621530] [10.1016/j.bmcl.2008.06.052]

Source